| Name | 2',2'-Difluoro-2'-deoxyuridine |
|---|---|
| Synonyms |
2(1H)-Pyrimidinone, 1-(2-deoxy-2,2-difluoro-β-D-erythro-pentofuranosyl)-4-hydroxy-
1-(2-Deoxy-2,2-difluoro-β-D-erythro-pentofuranosyl)-4-hydroxy-2(1H)-pyrimidinone Uridine, 2'-deoxy-2',2'-difluoro- Gemcitabine impurity C 2',2'-Difluoro-2'-deoxyuridine 2′,2′-difluorodeoxyuridine 2'-Deoxy-2',2'-difluorouridine |
| Description | 2′,2′-Difluorodeoxyuridine (dFdU) is the main metabolite of Gemcitabine (HY-17026). 2′,2′-Difluorodeoxyuridine causes a concentration- and schedule- dependent radiosensitising effect in vitro[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Melting Point | 147-149ºC |
| Molecular Formula | C9H10F2N2O5 |
| Molecular Weight | 264.183 |
| Exact Mass | 264.055786 |
| PSA | 104.55000 |
| LogP | -0.53 |
| Index of Refraction | 1.587 |
| Storage condition | -20°C Freezer |
|
~94%
114248-23-6 |
| Literature: ALIOS BIOPHARMA, INC.; Beigelman, Leonid; Wang, Guangyi; Smith, David Bernard; Deval, Jerome; Prhavc, Marija Patent: US2013/165400 A1, 2013 ; Location in patent: Paragraph 0420; 0421 ; |
|
~91%
114248-23-6 |
| Literature: Chou; Heath; Patterson; Poteet; Lakin; Hunt Synthesis, 1992 , # 6 p. 565 - 570 |
|
~%
114248-23-6 |
| Literature: US2013/165400 A1, ; |
|
~%
114248-23-6 |
| Literature: US2013/165400 A1, ; |
|
~%
114248-23-6 |
| Literature: Journal of Organic Chemistry, , vol. 53, # 11 p. 2406 - 2409 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |